🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#NCCN2022 Virtual Care is here to stay! 22 States with parity laws. #CancerTreatment ASCO National Comprehensive Cancer Network (NCCN) UW Health | Carbone Cancer Center

This is gonna be fun, so much has changed in advanced prostate cancer in just the last year alone! And I get to hang out with pretty fantastic clinician scientists 😊

#ASCO22 Important data presented by Robert Motzer MD of HRQoL and its association with clinical outcomes in patients with advanced #kidneycancer from the Checkmate-214 trial ASCO OncoAlert

UMANA IL receives "2022 Humanitarian Global Health Award". Thank you all for the efforts to support Ukraine! UW Health | Carbone Cancer Center UW Hematology-Oncology and Palliative Care ECOG-ACRIN Cancer Research Group Ulyana Khaba Douglas Davis umana.org/umana-illinois…

ESMO22 renal cancer highlights: 1st line trials: Cabo/ipi/nivo vs ipi/nivo (+veDFS).Bempegaldesleukin (peg il-2)+nivo vs VEGF TKI (-ve RR/OS). 2 negative adjuvant trials with atezo and ipi/nivo not showing a DFS advantage (in contrast to pembro). Finally a neoadjuvant nivo RIII.

From patient portal use patterns to NLP, our #ClinicalInformatics team was busy at the Department of Medicine Research Day! Peter Kleinschmidt Hamid Emamekhoo UW-Madison Critical Care Medicine Data Science Lab University of Wisconsin Department of Medicine

UW Applied Clinical Informatics Hamid Emamekhoo AnnWieben UW Health UW School of Medicine and Public Health UW Hematology-Oncology and Palliative Care Joel Gordon #2 in the world at effectively tracking signs, symptoms, or abnormal labs while on a study. This helps clinicians determine the true risk/benefit analysis of a new treatment.

I’m proud of our #UWinformatics team & our #clinicaltrial staff & investigators UW Health | Carbone Cancer Center for their dedication to outstanding care & their willingness to adopt a new platform! Their feedback made this EHR integrated AE reporting system a better tool. #XGM2023

Under the Bean in #Chicago with the ⁦UW Applied Clinical Informatics⁩ team attending #AMIA #CIC23 meeting.

The two keys for unlocking the productivity paradox! Nicely portrayed in the keynote presentation AMIA #CIC23 by Dr Robert Wachter. UW Applied Clinical Informatics

Congratulations to Dr. David Schneider Dave Schneider, Associate Program Director of our fellowship and Medical Informatics Director of Virtual Care UW Health on induction into the #FAMIA Class of 2023! UW-Madison Department of Surgery UW School of Medicine and Public Health AMIA

Considering #ePROs implementation for patients with #cancer at your institution? Checkout our new ⁦National Comprehensive Cancer Network (NCCN)⁩ ePRO WG paper published in ⁦ACS Journal Cancer. ⁦UW Health | Carbone Cancer Center⁩ ⁦UW Applied Clinical Informatics⁩ ⁦ASCO⁩ ⁦AMIA⁩ acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Concurrent durvalumab and radiation therapy #DUART followed by adjuvant durvalumab in pts with localized #UrothelialCancer of the #bladder: results from a P II study, BTCRC-GU15-023 #BeyondTheAbstract > bit.ly/3KJXong Hamid Emamekhoo UW Health | Carbone Cancer Center MJ Journal for ImmunoTherapy of Cancer

Great news for our patients with bladder cancer!! Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of OS and PFS in Certain Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer. ⁦UW Health | Carbone Cancer Center⁩ merck.com/news/merck-ann…

Fantastic GU committee ECOG-ACRIN Cancer Research Group meeting with ideas, concepts, discussion! Suzanne Cole, MD, FACP, FASCO Hamid Emamekhoo Martin Ma Naomi Haas MJ KMittaloncMD Jean Hoffman-Censits Kristen Spencer Elizabeth Plimack MD Nataliya Uboha Josh Lang Bladder Cancer Advocacy Network Stephanie Chisolm, PhD Neha Vapiwala Fred Hutch Cancer Center

End of meeting picture with fantastic friends and colleagues ⁦ECOG-ACRIN Cancer Research Group⁩ ⁦Petros Grivas⁩ ⁦Hamid Emamekhoo ➡️Appreciate the innovative ideas and emerging collaborations!

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer ASCO Guideline Update ascopubs.org/doi/full/10.12… The updated ASCO guideline provides evidence-based recommendations for the systemic treatment of patients with metastatic castration-resistant

📢 #ASCO25 | KEYNOTE-564 Ph. III | 5-Year Update (LBA–TBC): Adjuvant pembrolizumab vs placebo in high risk pts with ccRCC continues to show durable benefit—DFS HR 0.71 (DFS rate at 5 yrs 68.3% vs 52.2%) & OS HR 0.66 (OS rate at 5 yrs 87.7% vs 82.3%). No new safety signals.